Biogenic synthesis of nanoparticles mediated by microorganisms is a novel approach for creating antimicrobial agents

초록

Developing new and effective antimicrobial agents is essential for preventing bacteria resistance to widely used antibiotics. A new cure for this global problem is using nanoparticles (often inorganic) with antibacterial activities. Moreover, the development of nanoparticles requires the use of expensive, toxic, and hazardous substances that provide a variety of biological and environmental risks. This fact highlights the importance of establishing environmentally friendly processes via green synthesis (using plants) and nonbiological techniques (using microbes such as bacteria and fungi). Moreover, nanoparticles produced from fungi have shown potential as effective anticancer drugs and new-generation antimicrobial drugs. Furthermore, this chapter aims to investigate the numerous fungi that produce nanoparticles with the ultimate goal of revealing the potential, i.e., the process of different fungi's synthesis of NPs and this mycosynthesized NPs’ mechanism of action on bacterial cells. This chapter also enhances our knowledge of how nanoparticles interact with bacterial cells. © 2024 Elsevier Inc. All rights reserved.

키워드